{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:15:48Z","timestamp":1790741748247,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Glycogen storage diseases (GSD) encompass a group of rare inherited diseases due dysfunction of glycogen metabolism. Hypoglycemia is the most common primary manifestation of GSD, and disturbances in glucose metabolism can cause neurological damage. The aims of this study were to first investigate the metabolic, genetic, and neurological profiles of children with GSD, and to test the hypothesis whether GSD type I would have greater neurological impact than GSD type IX. A cross-sectional study was conducted with 12 children diagnosed with GSD [Types: Ia (n=5); 1, Ib (n=1); 4, IXa (n=5); and 1, IXb (n=1)]. Genetic testing was conducted for the following genes using multigene panel analysis. The biochemical data and magnetic resonance imaging of the brain presented by the patients were evaluated. The criteria of adequate metabolic control were adopted based on the European Study on Glycogen Storage Disease type I consensus. Pathogenic mutations were identified using multigene panel analyses. The mutations and clinical chronology were related to the disease course and neuroimaging findings. Adequate metabolic control was achieved in 67% of patients (GSD I, 43%; GSD IX, 100%). Fourteen different mutations were detected, and only two co-occurring mutations were observed across families (<jats:italic>G6PC<\/jats:italic> c.247C&amp;gt;T and c.1039C&amp;gt;T). Six previously unreported variants were identified (5 <jats:italic>PHKA2<\/jats:italic>; 1 <jats:italic>PHKB<\/jats:italic>). The proportion of GSD IX was higher in our cohort compared to other studies. Brain imaging abnormalities were more frequent among patients with GSD I, early-symptom onset, longer hospitalization, and inadequate metabolic control. The frequency of  mutations was similar to that observed among the North American and European populations. None of the mutations observed in <jats:italic>PHKA2<\/jats:italic> have been described previously. Therefore, current study reports six GSD variants previously unknown, and neurological consequences of GSD I. The principal neurological impact of GSD appeared to be related to inadequate metabolic control, especially hypoglycemia.<\/jats:p>","DOI":"10.3389\/fendo.2021.685272","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T07:38:07Z","timestamp":1621582687000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Neurological Characteristics of Pediatric Glycogen Storage Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Julio Henrique","family":"Muzetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Almeida","family":"do Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara L. S. Ferreira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Augusto","family":"Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara L.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.10.59","article-title":"Glycogen Metabolism and Glycogen Storage Disorders","volume":"6","author":"Kanungo","year":"2018","journal-title":"Ann Transl Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01176","article-title":"The Role of Brain Glycogen in Supporting Physiological Function","volume":"13","author":"Rich","year":"2019","journal-title":"Front Neurosci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1023\/A:1021831621210","article-title":"Glycogen Storage Diseases","volume":"4","author":"Wolfsdorf","year":"2003","journal-title":"Rev Endocr Metab Disord"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2016.01.002","article-title":"Evaluation of Central Nervous System in Patients With Glycogen Storage Disease Type 1a","volume":"58","author":"Aydemir","year":"2016","journal-title":"Turk J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-020-01573-8","article-title":"Diagnosis of Hepatic Glycogen Storage Disease Patients With Overlapping Clinical Symptoms by Massively Parallel Sequencing: A Systematic Review of Literature","volume":"15","author":"Beyzaei","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00431-002-0999-4","article-title":"Glycogen Storage Disease Type I: Diagnosis, Management, Clinical Course and Outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur J Pediatr Suppl"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0120","article-title":"Biochemical and Clinical Aspects of Glycogen Storage Diseases","volume":"238","author":"Ellingwood","year":"2018","journal-title":"J Endocrinol"},{"key":"B8","article-title":"Glycogen Storage Disease: Type I","volume-title":"Genereviews\u00ae","author":"Bali","year":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","article-title":"Glycogen Storage Disease Type IX: High Variability in Clinical Phenotype","volume":"92","author":"Beauchamp","year":"2007","journal-title":"Mol Genet Metab"},{"key":"B10","article-title":"Phosphorylase Kinase Deficiency Summary Genetic Counseling","volume-title":"Genereviews\u00ae","author":"Herbert","year":""},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.08.021","article-title":"Common Mutation in the PHKA2 Gene With Variable Phenotype in Patients With Liver Phosphorylase B Kinase Deficiency","volume":"104","author":"Achouitar","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B12","article-title":"Neurologic Manifestations of Hypoglycemia","volume-title":"Diabetes - Damages and Treatments","author":"Neil","year":"2011"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.04.06.db05-1314","article-title":"Cognitive and Neural Hippocampal Effects of Long-Term Moderate Recurrent Hypoglycemia","volume":"55","author":"McNay","year":"2006","journal-title":"Diabetes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.03.005","article-title":"Prevalence of Structural Central Nervous System Abnormalities in Early-Onset Type 1 Diabetes Mellitus","volume":"153","author":"Ho","year":"2008","journal-title":"J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1172-6-27","article-title":"Glucose-6-phosphatase Deficiency","volume":"6","author":"Froissart","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s004310051281","article-title":"Glycogen Storage Disease Type Ia: Recent Experience With Mutation Analysis, a Summary of Mutations Reported in the Literature and a Newly Developed Diagnostic Flowchart","volume":"159","author":"Rake","year":"2000","journal-title":"Eur J Pediatr"},{"key":"B18","article-title":"Genetic Basis of Glycogen Storage Disease Type 1a: Prevalent Mutations At the glucose-6-phosphatase Locus","volume":"57","author":"Lei","year":"1995","journal-title":"Am J Hum Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.5.358","article-title":"Mutation Analysis in 24 French Patients With Glycogen Storage Disease Type La","volume":"33","author":"Chevalier-Porst","year":"1996","journal-title":"J Med Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s100380170102","article-title":"Glycogen Storage Disease Type Ia: Molecular Study in Brazilian Patients","volume":"46","author":"Reis F de","year":"2001","journal-title":"J Hum Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1590\/S1415-47572013000400007","article-title":"Determining Mutations in G6PC and SLC37A4 Genes in a Sample of Brazilian Patients With Glycogen Storage Disease Types Ia and Ib","volume":"36","author":"Carlin","year":"2013","journal-title":"Genet Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(20000313)91:2<107::AID-AJMG5>3.0.CO;2-Y","article-title":"Glycogen Storage Disease Type Ia: Molecular Diagnosis of 51 Japanese Patients and Characterization of Splicing Mutations by Analysis of Ectopically Transcribed mRNA From Lymphoblastoid Cells","volume":"91","author":"Akanuma","year":"2000","journal-title":"Am J Med Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.7.1109","article-title":"Autosomal Glycogenosis of Liver and Muscle Due to Phosphorylase Kinase Deficiency is Caused by Mutations in the Phosphorylase Kinase \u03b2 Subunit (PHKB)","volume":"6","author":"Burwinkel","year":"1997","journal-title":"Hum Mol Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.634305","article-title":"Neonatal Hypoglycemia and Brain Vulnerability","volume":"12","author":"De Angelis","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30077","article-title":"Hypoglycemic Neuronal Death is Triggered by Glucose Reperfusion and Activation of Neuronal NADPH Oxidase","volume":"117","author":"Suh","year":"2007","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.11.2771","article-title":"The Impact of Acute Hypoglycemia on Neuropsychological and Neurometabolite Profiles in Children With Type 1 Diabetes","volume":"28","author":"Rankins","year":"2005","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.02.033","article-title":"Brain Damage in Glycogen Storage Disease Type I","volume":"144","author":"Melis","year":"2004","journal-title":"J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2003.12.008","article-title":"Symptomatic Occipital Lobe Epilepsy Following Neonatal Hypoglycemia","volume":"31","author":"Caraballo","year":"2004","journal-title":"Pediatr Neurol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12045","article-title":"Topography of Brain Damage in Metabolic Hypoglycaemia is Determined by Age At Which Hypoglycaemia Occurred","volume":"55","author":"Gataullina","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2013.02.005","article-title":"Dietary Treatment of Glycogen Storage Disease Type Ia: Uncooked Cornstarch and\/or Continuous Nocturnal Gastric Drip-Feeding","volume":"109","author":"Derks","year":"2013","journal-title":"Mol Genet Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.685272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T07:38:11Z","timestamp":1621582691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.685272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":30,"alternative-id":["10.3389\/fendo.2021.685272"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.685272","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"article-number":"685272"}}